Accurate Blood-Based Diagnostic Biosignatures for Alzheimer’s Disease via Automated Machine Learning
Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia and its timely diagnosis remains a major challenge in biomarker discovery. In the present study, we analyzed publicly available high-throughput low-sample -omics datasets from studies in AD blood, by the AutoML technology...
Main Authors: | Makrina Karaglani, Krystallia Gourlia, Ioannis Tsamardinos, Ekaterini Chatzaki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/3016 |
Similar Items
-
Deciphering the Methylation Landscape in Breast Cancer: Diagnostic and Prognostic Biosignatures through Automated Machine Learning
by: Maria Panagopoulou, et al.
Published: (2021-04-01) -
Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets
by: Georgios Papoutsoglou, et al.
Published: (2021-07-01) -
Somatic copy number aberrations detected in circulating tumor DNA can hold diagnostic value for early detection of hepatocellular carcinoma
by: Ekaterini Chatzaki, et al.
Published: (2020-07-01) -
Machine Learning Methods for Biosignature Discovery
Published: (2012) -
Alzheimer’s Disease Prediction Model Using Demographics and Categorical Data
by: Aunsia Khan, et al.
Published: (2019-12-01)